Author Archives: azaleaazelia
COVID-19 vaccine development part 21
Resources on COVID-19 vaccines development: WHO target product profile for COVID-19 vaccine Vaccine landscape Solidarity vaccine trial Access to COVID tools (ACT) Accelerator COVAX facility (WHO) Covax explained (GAVI) COPVAX (CEPI) WHO guidance on ethnics of vaccine allocation
Posted in Tak Berkategori
Leave a comment
COVID-19 vaccine development part 20
Working together to deliver vaccine to all countries: The Access to Covid-19 Tools (ACT) Accelerator was launched in April 2020 to speed up development and delivery to countries of diagnostics, treatments and vaccines. It includes a health systems connector to … Continue reading
Posted in Tak Berkategori
Leave a comment
COVID-19 vaccine development part 19
WHO Solidarity vaccine trial (Achieving rapid progress towards global objectives) : Evaluating several different candidate vaccines: Increasing the likelihood of finding several effective vaccines Expenditiously enrolling people at sites with high rates of COVID-19: … Continue reading
Posted in Tak Berkategori
Leave a comment
COVID-19 vaccine development part 18
WHO COVID-19 Solidarity vaccine trial : On 28 May 2020, WHO announced the launch of a coordinated international, concurrent randomized controlled Phase III trial of different vaccine candidates A trial in several sites at once will help speed evaluation and … Continue reading
Posted in Tak Berkategori
Leave a comment
COVID-19 vaccine development part 17
COVID-19 vaccine candidates in Phase III trials : As of 02 October 2020 there are 42 COVID-19 candidate vaccines in clinical evaluation of which 10 in phase III trials There are another 151 candidate vaccines in preclinical evaluation Phase III … Continue reading
Posted in Tak Berkategori
Leave a comment
